CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 170 enrolled
Drug / intervention
Ponto Sound processordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05356221
NCT05356221N/ACompleted

BC112 Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors

Oticon Medical·observational·Posted May 2, 2022·Updated Aug 17, 2025

In Brief

An observational study evaluating Ponto Sound processor for Hearing Loss and 2 related conditions. Completed, enrolled 170 participants across 1 site.

Detailed Summary

The study is a non-interventional, observational, cross-sectional, study on users of Ponto sound processors. The purpose of this study is to evaluate subjectively assessed hearing performance and satisfaction with Oticon Medical's sound processors fitted with the Genie Medical fitting software.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMay 2, 2022
Enrollment StartApr 11, 2022
Primary CompletionSep 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 4.2 years ago

Interventions

Ponto Sound processordevice

Bone Anchored Hearing solution fitted to compensate for the subjects hearing loss